Government has set up National Legal Services Authority (NALSA) under the Legal Services Authorities (LSA) Act, 1987 to provide free and competent legal services to the weaker sections of the society as covered under Section 12 of the Act, to ensure that opportunities for securing justice are not denied to ...
As on 30.11.2023, 25 Virtual Courts in 20 States / UTs viz. Delhi (2), Haryana, Chandigarh, Gujarat (2), Tamil Nadu, Karnataka, Kerala (2), Maharashtra (2), Assam, Chhattisgarh, Jammu and Kashmir (2), Uttar Pradesh, Odisha, Meghalaya, Himachal Pradesh, Uttarakhand, Madhya Pradesh, Tripura, West Bengal and Rajasthan, have been operationalized to handle ...
The following Act of Parliament received the assent of the President on the 28th September, 2023 and is hereby published for general information:— THE CONSTITUTION (ONE HUNDRED AND SIXTH AMENDMENT) ACT, 2023 [28th September, 2023.] An Act further to amend the Constitution of India. BE it enacted by Parliament in the Seventy-fourth ...
The following Act of Parliament received the assent of the President on the 11th August, 2023 and is hereby published for general information: THE DIGITAL PERSONAL DATA PROTECTION ACT, 2023 (NO. 22 OF 2023) [11th August, 2023.] An Act to provide for the processing of digital personal data in a manner that ...
Union Law Minister, Shri Kiren Rijiju felicitates the award winners of eCourts Project initiatives and An Appointment Software developed under the guidance of the Appointments Division The Department of Justice organised an award felicitation ceremony at Jaisalmer House, New Delhi today to honour the award winners of eCourts Project. The event ...
Some of the common practices by Pharmaceutical companies that ends up in a court rooms are Unlawful Kickbacks Clinical trials manipulation fraud against the Food and Drug Administration (FDA) Off-label marketing/Food Drug and Cosmetic Act (FDCA) violation Failure to comply with Current Good Manufacturing Practices (CGMP) requirements Compounded drug fraud Illegal drug-switching Misuse of the 340B drug discount ...